Cargando…
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern
BACKGROUND: The emergence of new SARS-CoV-2 variants of concern B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma) and B.1.617.2 (Delta) that harbor mutations in the viral S protein raised concern about activity of current vaccines and therapeutic antibodies. Independent studies have shown that mutant var...
Ejemplares similares
-
Humanized tau antibodies promote tau uptake by human microglia without any increase of inflammation
por: Zilkova, Monika, et al.
Publicado: (2020) -
Therapeutic antibody targeting microtubule-binding domain prevents neuronal internalization of extracellular tau via masking neuron surface proteoglycans
por: Weisová, Petronela, et al.
Publicado: (2019) -
Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer’s disease
por: Kontsekova, Eva, et al.
Publicado: (2014) -
Microglia display modest phagocytic capacity for extracellular tau oligomers
por: Majerova, Petra, et al.
Publicado: (2014) -
FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer’s disease
por: Novak, Petr, et al.
Publicado: (2018)